National Health Accounts in case of Latvia

Similar documents
Metadata (SHA 2011) Respondent. To be returned: By: 31/03/2017 To: OECD Eurostat WHO

Health Expenditure and Finance Data presented in OECD Health Data 2013 are based on:

Current health expenditure increased 3.0% in 2017

I. General questions on health accounting concepts and boundaries of SHA 2011

The Montenegro Health System Improvement Project. Tehnical Assistance in the Design and Production of the National Health Accounts in Montenegro

Working Group on Public Health statistics

Drug Reimbursement - Croatia. Roganovic Jelena

Classifications of Health Financing:

IMPLEMENTATION OF THE SYSTEM OF HEALTH ACCOUNTS: THE GREEK EXPERIENCE. Professor Em. L. Liaropoulos (Project coordinator)

Compulsory Health Insurance in Lithuania

National Accounts of Tajikistan

First Balkan Forum on: Health Care Reform

Report. National Health Accounts. of Armenia

HR 676: 35 Questions and Answers

DRAFT GUIDELINES FOR THE SHA 2011 FRAMEWORK FOR ACCOUNTING HEALTH CARE FINANCING

Estonian Health Care Expenditures in Ten Years Comparison

Draft Guidelines for the SHA 2011 Framework for Accounting Health Care Financing

Long-term care the problem of sustainable financing (Ljubljana, November 2014) 1

Securing stable revenue for health: Earmarking policy in Republic of Moldova

Disclosure Methodological Note For Aventis Pharma Ltd trading as Sanofi

Classification of Revenues of Health Care Financing Schemes (ICHA-FS)

2003 Multi-Beneficiary Programme for Statistical Co-operation with the Phare Countries FINAL REPORT ESTAT

Project Information Document/ Identification/Concept Stage (PID)

Expenditure tracking

Health Accounts Experts

National Treasury. Financing NHI. Pharmaceutical Society SA 24 June 2018

Health Sector Dynamics

Guidelines for the Notes on National Accounts Methodology

Belgian Health Care System. Jo DE COCK - CEO National Institute Health & Disability Insurance (NIHDI) Brussels 9 November 2011

LIFE ANSWERS FROM AARP

National Health Expenditure Accounts (NHEA) in the US

Reimbursement of Oncology Drugs in Saudi Arabia

Standardisation of Health and Social Services

Feedback from SHA non-participating countries. Prepared by: Vincent van Polanen Petel

Methodological Note to 2017 Disclosure Report for Aventis Pharma Limited Genzyme Therapeutics Limited and Sanofi Pasteur

Progress report from Statistics Vietnam

MANAGEMENT ENTRY STRATEGIES: SPAIN S CASE

National Health Accounts Report. Bermuda health system finance and expenditure for fiscal year

INDUSTRY TRENDS IN PHARMACY REIMBURSEMENT

Glossary. Last Reviewed 11/10/14

Universal health coverage roadmap Private sector engagement to improve healthcare access

Investigating Welfare on the Income and Expenditure Survey

UNITED NATIONS NPI HANDBOOK

OECD Health Accounts Experts meeting. Joint Eurostat/OECD Report on the Results from the 2 nd Pilot based on SHA 2011

PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME *

METHODOLOGY NOTES. TRANSPARENCY DISCLOSURE FOR TRANSFERS OF VALUE (ToV) TO HEALTHCARE PROFESSIONALS (HCP) AND HEALTHCARE ORGANISATIONS (HCO)

IMPLEMENTING THE CAPITAL ACCOUNT IN SHA 2011

The Role of the Private Sector in Expanding Health Access to the Base of the Pyramid

AFFORDABLE CARE ACT SMALL EMPLOYER HEALTH REFORM CHECKLIST. Edition: November 2014

Preliminary summary the triangle and the building blocks (functions)

Measuring Universal Coverage

Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018

Improving data on pharmaceuticals. Meeting of OECD Health Data National Correspondents 3-4 october 2011

ACA for Employers Employee Benefits Conference May 15, 2015

National Pharmaceutical Sector Form of Mongolia

GUIDELINES FOR THE DELINEATION INTO PUBLIC AND PRIVATE UNITS

ESTIMATES OF GDP CONTRIBUTION OF THE INFORMAL ECONOMY Current Practice in Mongolia

Will India Embrace UHC?

Indonesia National Health Accounts 2016 Presented in INAHEA 5 th Conference Jakarta, 31 October 2 November 2018

The financing dimension in SHA 2011

Reporting of Transfers of Value to HCPs and HCOs Methodological Note for Reporting of 2017 Data in 2018

ANOC2019. Annual Notice of Changes. SuperiorSelectMedicare.com

Help with health costs

Manufacturer Patient Support Initiatives: Current Practices and Recent Challenges. Andrew Ruskin Morgan Lewis

Making the case for Horizon Scanning

Health Care Financing: Looking Towards Kurdistan s Future

Moderator: J van Loon,MSc Mapi. Advisor to the President, Head of International Affairs, HAS France

Help with health costs

MONGOLIAN HEALTH INSURANCE SCHEME

A Belgian cooperation platform Thomas Rousseau NIHDI - COOPAMI. Thomas Rousseau NIHDI - COOPAMI 2

Ethical Rules for Collaboration between Patient Groups, etc. and the Pharmaceutical Industry

PROJECT INFORMATION DOCUMENT (PID) APPRAISAL STAGE

Pocket Statistics. The Social Insurance Institution of Finland

Health Financing Reform for UHC

Initial Functional Medicine (FM) Consult $475 FM follow up visits $175 Convenient Care Visit $125. Action Plan/Health Care Consult Visit $50

GLOSSARY. MEDICAID: A joint federal and state program that helps people with low incomes and limited resources pay health care costs.

Medicare Part D Amounts Will Increase in 2015

Co-pay Accumulator Adjustment Programs

VAT Guidance for General Practitioners

Country Report UZBEKISTAN

Current practice and status of the national accounts compilation in Uzbekistan

The Performance of the Greek NHS and the Economic Adjustment Programme. Babis Economou Assistant Professor, Panteion University

SYSTEM. Ri DE RIDDER Chief Executive of the Health Care Department NIHDI

Application for Assistance (please print)

Thomas Rousseau NIHDI - COOPAMI 2. Ulla Cahay NIHDI - COOPAMI

OECD Health Policy Unit. 10 June, 2001

Medicines for Europe (MFE) HCP/HCO/PO Disclosure Transparency Requirements. Samsung Bioepis Methodology Note

AccessCUBICIN Enrollment Form

Social Health Protection In Lao PDR

Guidelines for the Notes on National Accounts Methodology

MEDICARE PRESCRIPTION DRUG LEGISLATION: Part D Benefits and Employer Subsidies. December 2003

Accounting Separation Methodology Statement for 2016/17

Medicare Prescription Drug, Improvement and Modernization Act

REPORT OF THE COUNCIL ON MEDICAL SERVICE. (J. Leonard Lichtenfeld, MD, Chair)

Lawyer Chief Expert at the Ministry of Health

OPERS Health Care. Understanding the Basics 2019: Medicare and the OPERS Medicare Connector administered by Via BenefitsTM.

12TH OECD-NBS WORKSHOP ON NATIONAL ACCOUNTS MEASUREMENT OF HEALTH SERVICES. Comments by Luca Lorenzoni, Health Division, OECD

Florida s Risk Management Program State Workers Compensation Program Cost Drivers Presentation to the Senate Budget Committee November 16, 2011

ARPIM HCP/HCO DISCLOSURE CODE

Spain. Health Care & Long-Term Care Systems

Transcription:

National Health Accounts in case of Latvia Dace Krievkalne Culture, Education, Science and Health Statistics Section Luxsembourg, 28-29 November 2016

Content 1. National SHA background and insights 2. Key principles of data collection: Data sources Approuch of data collection Pros and Cons Problems and Challenges 2

From 2005 to 2015 (1) Different working groups, seminars, TFs Experts visits and consultations Several projects (ICON-INSTITUT 2005, Grants 2007, 2014) Time constraints and doubts about the occuracy Data quality improvements and corrections Transition to the new SHA 2011 Good experience for creating and developing National Health Accounts 3

From 2005 to 2015 (2) 1600 000 1400 000 SHA1.0 1200 000 1000 000 800 000 600 000 400 000 200 000 - SHA2011 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 Total health ependiture General governmebt expenditure Out-of-pocket expenditure MoH 4

Key principles Data sources Residual method for HF.3 Bottom-up approuch Provider side 5

Data sources (1) National Health Service covers approx. 80-85% of the whole budget of the Ministry of Health except functions HC.3.2; HC.4.3; HC.512; HC.6.1; HC.6.5-6.6, HC.7.1 and providers HP.2, HP.3.5; HP.4.1; HP.5.2; HP.5.9; HP.7.2-7.3; HP.8.1 Main partner for data collection not only for SHA but also for nonexpenditure data and other data request (for instance, PPP) During the Grant 2014 project, NHS improved IT solutions and introduced HP and HC classification into Management Information System that will help to keep the succession of data collection 6

Data sources (2) Central Statistical Bureau Integrated Statistical data Management system (including data on bugetary institutions, local government units, self-employed persons, Register of enterprises, quarterly and yearly questionnaires, questionnairies on investments HBS, LFS and other surveys other data sources for which we have an access (State Business register, home-pages, reports) 7

Data sources (3) State Agency of Medicines Summary on operation of pharmacies, wholesale medical companies and drug production companies Ministry of Welfare Long-term care services Therapeutic appliances and other medical durable goods Disability statistics Ministry of Health Programms that are not covered by NHS Centre for Disease Prevention and Control Non-expenditure data for calculations and estimates 8

Provider side approach (1) Health providers Number One common list of providers with NHS, Health Inspectorate and Centre for Disease Prevention and Control HP.1 66 Y HP.2 15 HP.3 3 998 Y HP.4 34 Y HP.5 848 HP.6 4 Y HP.7 11 Y HP.8 574 Partly TOTAL 5 550 9

Provider side approach (2) Structure of health providers HP.7 0.2% HP.6 0.1% HP.4 0.6% HP.8 10.3% HP.5 15.3% HP.3 [PERCENTAGE] HP.3.1 42.8% HP.3.2 14.8% HP.2 0.3% HP.1 1.2% HP.3.5 0.2% HP.3.4 2.7% HP.3.3 11.6% 10

Provider side (3) HP.6 0.7% HP.7 1.9% HP.4 10.3% HP.5 15.8% HP/HF.1 HP.8 0.8% HP.9 1.2% HP.1 45.4% HP.6 HP.7 0.1% 1.1% HP.5 51.0% HP/HF.3 HP.8 HP.9 0.0% 0.0% HP.1 15.8% HP.3 27.6% HP.2 1.7% HP.3 19.5% HP.2 4.4% HP.4 2.7%

Residual method (1) Residual method is used mainly for calculation private expenditure (PrE): The main variables that are taken from the CSB database are: Net turnover (according to the profit or loss statement); From net turnover - grants and subsidies (if they are included in net turnover) PrE = provider s turnover grants and subsidies CSB sub+g - NHS = 0 OK CSB sub+g - NHS > 0 OK CSB sub+g - NHS < 0! The main variables that are taken from the NHS database are: Total State funding per institution and functios

Prosp and cons (1) Common health providers list (HP) for all involved health data holders in the country Opportunity to calculate pure branch health and without weights Opportunity to use different sectors (for instance, government sector and private sector) Good platform for calculation tables on investments Opportunity to split HP into more detailed level, for instance, HP.3.1.1. GP practices or HP.3.1.2 psychiatrist medical practice Avoiding double counting 13

Prosp and cons (2) However... List of providers is sensitive to changes in the forms of enterprise activities and NACE classification Dependance on the accuracy of accountants filling in questionnaires For some providers (HP.21, HP.52 or HP.4 it is difficult to find providers using NACE and HA definitions Time consuming process. For NHS it takes 2 months, for CSB 3-4 months FTE. 14

Problems and Challenges (1) 1. Improvement of the data quality for household out-ofpocket payment by splitting private expenditure into HF.3.1 Out-of-pocket excluding cost-sharing and HF.3.2 Cost-sharing with third-party payers 2. The estimation of health services provided for nonresidents 3. Introduction of the additional SHA tables (HFxFS), (HPxFP) and HKxHP 15

Problems and Challenges (2) 4. Improvements to the main data tables by filling empty cells or supplementing them: Households as providers of home health care (HP.8.1) Patient transportation HC.4.3 Information, education and counselling programmes HC.6.1 5. Answers to the questions: Do we need in SHA medical professionals expenditure for professional certification and re-certification? How to deal with donations? SPA and welness services 16

Problems and Challenges (3) 6. How to reflect the expenditure of healthcare from different data sources? 7. Processes determined by health policy planning documents continue to take place in Latvia. Priorities are being set in health care, and they will certainly reflect in the collection of health care data (hospital reorganisation process, increase in the number of day hospital services, implementation of e- Health, EU funds for 2014 2020, etc.) 17

% Examples of different results reflect health spending 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 Total health expenditure (according to SHA), % from GDP General Government expenditure (according to SHA), % from GDP Household out-of-pocket payments (according to SHA) Total health expenditure (according to SNA), % from GDP Health S14 (according to SNA), % from GDP HH expenditure for health from total HH expenditure

Thank you for your attention! 1 9